Procter & Gamble Health has informed that it attached Company's communication with respect to deduction of TDS on the amount of dividend proposed for final dividend for the financial year 2024-25, subject to approval of the shareholders at the ensuing annual general meeting.
The above information is a part of company’s filings submitted to BSE